Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stella

Showing results (181-190 of 271) with videos related to

Pageof 28
Sort By:
Pharmaceutical Research|November 1, 1996
The effect of conformation on membrane permeability of an acyloxyalkoxy-linked cyclic prodrug of a model hexapeptideS Gangwar, S D Jois, T J Siahaan, et al.
Journal of Drug Targeting|January 1, 1997
Derivatives of melphalan designed to enhance drug accumulation in cancer cellsL Kupczyk-Subotkowska, K Tamura, D Pal, et al.
JNCI Cancer Spectrum|April 16, 2021
DeImplementing Ineffective and Low-Value Clinical Practices: Research and Practice Opportunities in Community Oncology SettingsWynne E Norton, Worta McCaskill-Stevens, David A Chambers, et al.
Journal of Biomedical Optics|July 9, 2020
Selecting optimal spectral bands for improved detection of autofluorescent biomarkers in multiphoton microscopyBjörn-Ole Meyer, M. Pilar J. Stella, Bjørn Holst, et al.
Journal of Pharmaceutical Sciences|September 24, 2009
Preparation and physicochemical characterization of a novel water-soluble prodrug of carbamazepineJeffrey N Hemenway, Pekka Jarho, John T Henri, et al.
Carbohydrate Research|April 21, 1997
Isolation and characterization by NMR spectroscopy of three monosubstituted 4-sulfobutyl ether derivatives of cyclomaltoheptaose (beta-cyclodextrin)E A Luna, D G Vander Velde, R J Tait, et al.
Pharmaceutical Research|May 5, 1999
Design and evaluation of an osmotic pump tablet (OPT) for chlorpromazine using (SBE)7m-beta-CDK Okimoto, A Ohike, R Ibuki, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 30, 1999
Factors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)(7m)-beta-CD as both a solubilizer and osmotic agentK Okimoto, A Ohike, R Ibuki, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 1, 1996
Evaluation of the utility of capillary electrophoresis for the analysis of sulfobutyl ether beta-cyclodextrin mixturesE A Luna, E R Bornancini, R J Tait, et al.
Journal of Oncology Practice|July 14, 2016
Toxicity-Related Factors Associated With Use of Services Among Community Oncology PatientsJordan M Harrison, Philip J Stella, Beth LaVasseur, et al.
Pageof 28

Showing results (181-190 of 271) with videos related to

Sort By:
Pageof 28
Pharmaceutical Research|November 1, 1996
The effect of conformation on membrane permeability of an acyloxyalkoxy-linked cyclic prodrug of a model hexapeptideS Gangwar, S D Jois, T J Siahaan, et al.
Journal of Drug Targeting|January 1, 1997
Derivatives of melphalan designed to enhance drug accumulation in cancer cellsL Kupczyk-Subotkowska, K Tamura, D Pal, et al.
JNCI Cancer Spectrum|April 16, 2021
DeImplementing Ineffective and Low-Value Clinical Practices: Research and Practice Opportunities in Community Oncology SettingsWynne E Norton, Worta McCaskill-Stevens, David A Chambers, et al.
Journal of Biomedical Optics|July 9, 2020
Selecting optimal spectral bands for improved detection of autofluorescent biomarkers in multiphoton microscopyBjörn-Ole Meyer, M. Pilar J. Stella, Bjørn Holst, et al.
Journal of Pharmaceutical Sciences|September 24, 2009
Preparation and physicochemical characterization of a novel water-soluble prodrug of carbamazepineJeffrey N Hemenway, Pekka Jarho, John T Henri, et al.
Carbohydrate Research|April 21, 1997
Isolation and characterization by NMR spectroscopy of three monosubstituted 4-sulfobutyl ether derivatives of cyclomaltoheptaose (beta-cyclodextrin)E A Luna, D G Vander Velde, R J Tait, et al.
Pharmaceutical Research|May 5, 1999
Design and evaluation of an osmotic pump tablet (OPT) for chlorpromazine using (SBE)7m-beta-CDK Okimoto, A Ohike, R Ibuki, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 30, 1999
Factors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)(7m)-beta-CD as both a solubilizer and osmotic agentK Okimoto, A Ohike, R Ibuki, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 1, 1996
Evaluation of the utility of capillary electrophoresis for the analysis of sulfobutyl ether beta-cyclodextrin mixturesE A Luna, E R Bornancini, R J Tait, et al.
Journal of Oncology Practice|July 14, 2016
Toxicity-Related Factors Associated With Use of Services Among Community Oncology PatientsJordan M Harrison, Philip J Stella, Beth LaVasseur, et al.
Pageof 28